<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02384096</url>
  </required_header>
  <id_info>
    <org_study_id>90968587</org_study_id>
    <nct_id>NCT02384096</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes</brief_title>
  <acronym>COVERAGE</acronym>
  <official_title>COVERAGE - A Study to Evaluate the Effect of Precision Spectra™ SCS System's Programming Features and Lead Options on Patient Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective, on-label, multi-center, blinded, randomized controlled trial with
      a cross-over design to evaluate the effect of Precision Spectra™ SCS System's programming
      features and lead options.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a sub-study of RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of
      Neurostimulation Therapy for Pain. The treatment will consist of permanent implant of a
      Precision Spectra™ SCS IPG with either a 32 contact CoverEdge™ Surgical Lead or with more
      than 2 percutaneous leads after a successful trial. Programming features and lead options of
      the Precision Spectra™ SCS System will be evaluated up to 3 months post-IPG activation.
      Following completion of the 3 month visit, subjects will continue to be followed for up to 36
      months per the study requirements of the RELIEF Registry.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in percent paresthesia coverage of targeted pain while minimizing unwanted paresthesia</measure>
    <time_frame>7, 14 days post activation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Surgical lead</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Precision Spectra SCS System with CoverEdge Surgical Lead. Subjects will be randomized to receive conventional single source programming followed by Precision Spectra SCS System advanced programming or Precision Spectra SCS System advanced programming followed by conventional single source programming.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous leads</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Precision Spectra SCS System with more than 2 percutaneous leads. Subjects will be randomized to receive conventional single source programming followed by Precision Spectra SCS System advanced programming or Precision Spectra SCS System advanced programming followed by conventional single source programming.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional single source programming</intervention_name>
    <description>Precision Spectra SCS System using conventional single source programming.</description>
    <arm_group_label>Surgical lead</arm_group_label>
    <arm_group_label>Percutaneous leads</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Precision Spectra SCS System advanced programming</intervention_name>
    <description>Precision Spectra SCS System using advanced programming</description>
    <arm_group_label>Surgical lead</arm_group_label>
    <arm_group_label>Percutaneous leads</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets RELIEF Registry criteria for inclusion

          -  Primary complaint of persistent or recurrent low back pain, with or without leg pain

          -  Signed a valid, IRB/EC-approved informed consent form

        Exclusion Criteria:

          -  Meets any RELIEF Registry criteria for exclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen Lechleiter, M.S.</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Neuromodulation Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research Information Toll Free Number</name>
      <address>
        <city>Valencia</city>
        <state>California</state>
        <zip>91355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2015</study_first_posted>
  <last_update_submitted>December 1, 2016</last_update_submitted>
  <last_update_submitted_qc>December 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stimulation</keyword>
  <keyword>implantable</keyword>
  <keyword>pulse generator</keyword>
  <keyword>back pain</keyword>
  <keyword>chronic pain</keyword>
  <keyword>leg pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 13, 2017</submitted>
    <returned>November 13, 2017</returned>
    <submitted>February 13, 2018</submitted>
    <returned>March 12, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

